341 related articles for article (PubMed ID: 8640331)
1. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart.
Chatelain P; Meysmans L; Mattéazzi JR; Beaufort P; Clinet M
Br J Pharmacol; 1995 Oct; 116(3):1949-56. PubMed ID: 8640331
[TBL] [Abstract][Full Text] [Related]
2. Cardiac beta-adrenoceptor modulation by amiodarone.
Nokin P; Clinet M; Schoenfeld P
Biochem Pharmacol; 1983 Sep; 32(17):2473-7. PubMed ID: 6311220
[TBL] [Abstract][Full Text] [Related]
3. Interaction of amiodarone and triiodothyronine on the expression of beta-adrenoceptors in brown adipose tissue of rat.
Adli H; Bazin R; Perret GY
Br J Pharmacol; 1999 Mar; 126(6):1455-61. PubMed ID: 10217540
[TBL] [Abstract][Full Text] [Related]
4. Control of cultured epithelial (MDCK) cell transport function: identification of a beta-adrenoceptor coupled to adenylate cyclase.
Rugg EL; Simmons NL
Q J Exp Physiol; 1984 Apr; 69(2):339-53. PubMed ID: 6328561
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a decrease in the efficiency of beta-receptor coupling to adenylate cyclase in liver membranes from sucrose-fed rats.
Lynch CJ; Steer ML; Connors MR; Schatz RA; Deth RC
Biochem Pharmacol; 1985 Mar; 34(5):623-9. PubMed ID: 2983731
[TBL] [Abstract][Full Text] [Related]
6. Adenylate cyclase agonist properties of CGP-12177A in brown fat: evidence for atypical beta-adrenergic receptors.
Scarpace PJ; Matheny M
Am J Physiol; 1991 Feb; 260(2 Pt 1):E226-31. PubMed ID: 1671733
[TBL] [Abstract][Full Text] [Related]
7. SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs.
Hodeige D; Heyndrickx JP; Chatelain P; Manning A
Eur J Pharmacol; 1995 Jun; 279(1):25-32. PubMed ID: 7556379
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone. Biochemical aspects and haemodynamic effects.
Gagnol JP; Devos C; Clinet M; Nokin P
Drugs; 1985 Mar; 29 Suppl 3():1-10. PubMed ID: 2986937
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitro.
Freissmuth M; Tuisl E; Steurer G; Schütz W
Eur J Pharmacol; 1984 Sep; 104(1-2):169-72. PubMed ID: 6094208
[TBL] [Abstract][Full Text] [Related]
10. The relationship between beta-adrenoceptor regulation and beta-adrenergic responsiveness in hepatocytes. Studies on acquisition, desensitization and resensitization of isoproterenol-sensitive adenylate cyclase in primary culture.
Refsnes M; Sandnes D; Christoffersen T
Eur J Biochem; 1987 Mar; 163(3):457-66. PubMed ID: 3030743
[TBL] [Abstract][Full Text] [Related]
11. Enhanced adenylate cyclase activity of turkey erythrocytes following treatment with beta-adrenergic receptor antagonists.
Peters JR; Nambi P; Sibley DR; Lefkowitz RJ
Eur J Pharmacol; 1984 Dec; 107(1):43-52. PubMed ID: 6151904
[TBL] [Abstract][Full Text] [Related]
12. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
Roberts SJ; Molenaar P; Summers RJ
Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926
[TBL] [Abstract][Full Text] [Related]
13. Receptor crosstalk: effects of prolonged carbachol exposure on beta 1-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes.
Paraschos A; Karliner JS
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):267-76. PubMed ID: 7824043
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptor-G alpha S coupling decreases with age in rat aorta.
Gurdal H; Friedman E; Johnson MD
Mol Pharmacol; 1995 Apr; 47(4):772-8. PubMed ID: 7723738
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic pindolol treatment on human myocardial beta 1- and beta 2-adrenoceptor function.
Bjørnerheim R; Golf S; Hansson V
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):429-35. PubMed ID: 2175014
[TBL] [Abstract][Full Text] [Related]
16. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
Findell PR; Wong KH; Jackman JK; Daniels DV
Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
[TBL] [Abstract][Full Text] [Related]
17. Relationship between desensitization and downregulation of beta-adrenoceptors in cardiac tissues after prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor agonist.
Sato Y; Kurose H; Nagao T
Jpn J Pharmacol; 1997 Apr; 73(4):325-32. PubMed ID: 9165369
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor adenylate cyclase system adaptation to physical training in rat ventricular tissue.
Plourde G; Rousseau-Migneron S; Nadeau A
J Appl Physiol (1985); 1991 Apr; 70(4):1633-8. PubMed ID: 1647390
[TBL] [Abstract][Full Text] [Related]
19. Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro.
Standifer KM; Pitha J; Baker SP
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):129-37. PubMed ID: 2566922
[TBL] [Abstract][Full Text] [Related]
20. Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system.
Freissmuth M; Schütz W; Weindlmayer-Göttel M; Zimpfer M; Spiss CK
J Cardiovasc Pharmacol; 1987 Nov; 10(5):568-74. PubMed ID: 2447407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
